• 1
    Bond BR, Fox PR, Peterson ME, et al. Echocardiographic findings in 103 cats with hyperthyroidism. J Am Vet Med Assoc 1988;192:15461549.
  • 2
    Weichselbaum RC, Feeney DA, Jessen CR. Relationship between selected echocardiographic variables before and after radioiodine treatment in 91 hyperthyroid cats. Vet Radiol Ultrasound 2005;46:506513.
  • 3
    Paige CF, Abbott JA, Elvinger F, et al. Prevalence of cardiomyopathy in apparently healthy cats. J Am Vet Med Assoc 2009;234:13981403.
  • 4
    Nakamura RK, Rishniw M, King MK, et al. Prevalence of echocardiographic evidence of cardiac disease in apparently healthy cats with murmurs. J Feline Med Surg 2011;13:266271.
  • 5
    Wagner T, Fuentes VL, Payne JR, et al. Comparison of auscultatory and echocardiographic findings in healthy adult cats. J Vet Cardiol 2010;12:171182.
  • 6
    Trehiou-Sechi E, Tissier R, Gouni V, et al. Comparative echocardiographic and clinical features of hypertrophic cardiomyopathy in 5 breeds of cats: A retrospective analysis of 344 cases (2001-2011). J Vet Intern Med 2012;26:532541.
  • 7
    Schultz M, Faber J, Kistorp C, et al. N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP) in different thyroid function states. Clin Endocrinol (Oxf) 2004;60:5459.
  • 8
    Ozmen B, Ozmen D, Parildar Z, et al. Serum N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP) levels in hyperthyroidism and hypothyroidism. Endocr Res 2007;32:18.
  • 9
    Ertugrul DT, Gursoy A, Sahin M, et al. Evaluation of brain natriuretic peptide levels in hyperthyroidism and hypothyroidism. J Natl Med Assoc 2008;100:401405.
  • 10
    Kohno M, Horio T, Yasunari K, et al. Stimulation of brain natriuretic peptide release from the heart by thyroid hormone. Metabolism 1993;42:10591064.
  • 11
    Menaut P, Connolly DJ, Volk A, et al. Circulating natriuretic peptide concentrations in hyperthyroid cats. J Small Anim Pract 2012;53:673678.
  • 12
    Connolly DJ, Guitian J, Boswood A, et al. Serum troponin I levels in hyperthyroid cats before and after treatment with radioactive iodine. J Feline Med Surg 2005;7:289300.
  • 13
    Wess G, Daisenberger P, Mahling M, et al. Utility of measuring plasma N-terminal pro-brain natriuretic peptide in detecting hypertrophic cardiomyopathy and differentiating grades of severity in cats. Vet Clin Pathol 2011;40:237244.
  • 14
    Tominaga Y, Miyagawa Y, Toda N, et al. The diagnostic significance of plasma N-terminal pro-B-type natriuretic peptide concentration in asymptomatic cats with cardiac enlargement. J Vet Med Sci 2011;73:971975.
  • 15
    Fox PR, Oyama MA, Reynolds C, et al. Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats. J Vet Cardiol 2009;11(Suppl. 1):S51S61.
  • 16
    Sleeper MM, Clifford CA, Laster LL. Cardiac troponin I in the normal dog and cat. J Vet Intern Med 2001;15:501503.
  • 17
    Thomas WP, Gaber CE, Jacobs GJ, et al. Recommendations for standards in transthoracic two-dimensional echocardiography in the dog and cat. J Vet Intern Med 1993;7:247252.
  • 18
    Herndon WE, Kittleson MD, Sanderson K, et al. Cardiac troponin I in feline hypertrophic cardiomyopathy. J Vet Intern Med 2002;16:558564.
  • 19
    Connolly DJ, Cannata J, Boswood A, et al. Cardiac troponin I in cats with hypertrophic cardiomyopathy. J Feline Med Surg 2003;5:209216.
  • 20
    Herndon WE, Rishniw M, Schrope D, et al. Assessment of plasma cardiac troponin I concentration as a means to differentiate cardiac and noncardiac causes of dyspnea in cats. J Am Vet Med Assoc 2008;233:12611264.
  • 21
    Connolly DJ, Brodbelt DC, Copeland H, et al. Assessment of the diagnostic accuracy of circulating cardiac troponin I concentration to distinguish between cats with cardiac and non-cardiac causes of respiratory distress. J Vet Cardiol 2009;11:7178.
  • 22
    Adin DB, Oyama MA, Sleeper MM, et al. Comparison of canine cardiac troponin I concentrations as determined by 3 analyzers. J Vet Intern Med 2006;20:11361142.
  • 23
    Fox PR, Rush JE, Reynolds CA, et al. Multicenter evaluation of plasma N-terminal probrain natriuretic peptide (NT-pro BNP) as a biochemical screening test for asymptomatic (occult) cardiomyopathy in cats. J Vet Intern Med 2011;25:10101016.
  • 24
    Hsu A, Kittleson MD, Paling A. Investigation into the use of plasma NT-proBNP concentration to screen for feline hypertrophic cardiomyopathy. J Vet Cardiol 2009;11(Suppl. 1):S63S70.
  • 25
    Singh MK, Cocchiaro MF, Kittleson MD. NT-proBNP measurement fails to reliably identify subclinical hypertrophic cardiomyopathy in Maine Coon cats. J Feline Med Surg 2010;12:942947.
  • 26
    Nunes JP. Cardiac troponin I in systemic diseases. A possible role for myocardial strain. Rev Port Cardiol 2001;20:785788.
  • 27
    Pahle AS, Sorli D, Omland T, et al. Impact of systemic hypertension on the diagnostic performance of B-type natriuretic peptide in patients with acute dyspnea. Am J Cardiol 2009;104:966971.
  • 28
    Lalor SM, Connolly DJ, Elliott J, et al. Plasma concentrations of natriuretic peptides in normal cats and normotensive and hypertensive cats with chronic kidney disease. J Vet Cardiol 2009;11(Suppl. 1):S71S79.
  • 29
    Bland JM, Altman DG. Measurement error. BMJ 1996;313:744.
  • 30
    Chetboul V, Concordet D, Pouchelon JL, et al. Effects of inter- and intra-observer variability on echocardiographic measurements in awake cats. J Vet Med A 2003;50:326331.